

Silence Therapeutics
SLN:LNLondon Stock Exchange (AIM)
Overview
Company Profile
Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange (AIM)
BoardAIM
